Azacitidine With or Without Lenalidomide or Vorinostat in Treating Patients With Higher-Risk Myelodysplastic Syndromes or Chronic Myelomonocytic Leukemia
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Center for International Blood and Marrow Transplant Research
Memorial Sloan Kettering Cancer Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Ohio State University Comprehensive Cancer Center
Children's Hospital Medical Center, Cincinnati
M.D. Anderson Cancer Center
Children's Hospital of Philadelphia
M.D. Anderson Cancer Center
University Hospital Tuebingen
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
The University of Hong Kong
City of Hope Medical Center
Thomas Jefferson University
Istituto Clinico Humanitas
Fred Hutchinson Cancer Center
Rigshospitalet, Denmark
University of Leipzig
Virginia Commonwealth University
M.D. Anderson Cancer Center
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Fred Hutchinson Cancer Center
National Cancer Institute (NCI)
Loyola University
CTI BioPharma
Masonic Cancer Center, University of Minnesota
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Maryland, Baltimore
Nohla Therapeutics, Inc.
National Heart, Lung, and Blood Institute (NHLBI)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Indiana University
Cedars-Sinai Medical Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
University of Washington
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center